BioCentury
ARTICLE | Clinical News

FDA regulatory update

February 26, 1996 8:00 AM UTC

FDA said it is publishing a final guideline on the quality of biotechnological products entitled "Analysis of the Expression Construct in Cells Used for Production of r-DNA Derived Protein Products."

The guideline was prepared under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). ...